FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3184871422> ?p ?o ?g. }

• W3184871422 endingPage "1683" @default.
• W3184871422 startingPage "1681" @default.
• W3184871422 abstract "The paper by Li and coworkers1 in this issue of the Journal provides several new insights into the significant relationships of three parameters in day-to-day SBP variability–that is, standard derivation [SD], coefficient of variation [CV], and variability independent of mean [VIM]–with worse clinical outcomes in 79 hospitalized patients with COVID-19.1 Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and currently a worldwide pandemic, includes in its pathophysiology an excessive inflammatory phase called a “cytokine storm” that is closely linked to its high mortality.2 This storm leads to activation of immune cells, release of inflammatory cytokines, and recruitment of further cells of the immune system.3 When this immune response is exaggerated, excessive inflammation leads to end tissue damage and organ failure. In general, the cytokine storm is thought to be caused by an imbalance of the autonomic nervous system (ANS),4 which is linked to overexcitation of the illness-adaptive sympathetic nervous system (SNS) to maintain homeostasis.4, 5 Indeed, an imbalance of the ANS has been suggested to determine the severity of courses in COVID-19.6 While hypertension is an important predictor of cardiovascular disease (CVD),7 blood pressure (BP) fluctuation is partially caused by changes in internal physical status. In the UK-TIA Aspirin Trial and the ASCOT-BPLA, visit-to-visit systolic BP (SBP) variability was shown to be a strong predictor of stroke independent of average SBP.8 Day-to-day home SBP variability was also associated with the poor prognosis of the Japanese at high risk of CVD.9 In a recent analysis of COVID-19, a significant association between higher BP levels at admission and higher mortality was demonstrated,10 and poor BP control was also found to be independently associated with a higher risk of an adverse outcome in COVID-19.11 Thus, Li and coworkers1 added increased day-to-day BP variability as a non-conventional risk factor for poor prognosis in hospitalized patients with COVID-19. Several mechanisms have been considered to play roles in the pathophysiology of COVID-19 including systemic inflammation, disrupted cardiopulmonary coupling, and cardiac insufficiency to compromise BP regulation, and any of these mechanisms could potentially lead to the increased BP variability that precedes the deterioration of general condition in some patients with COVID-19.1 Although the causes of abnormal BP variability are still under debate, an autonomic factor specifically, SNS overactivity is likely to be involved.12 As mentioned above, SARS-CoV-2 infection induces an excessive immune reaction leading to a fatal cytokine storm and multi-organ failure. This storm involves the release of considerable amounts of proinflammatory cytokine including IL-6 and TNF-α.13 These mediators can subsequently cross the blood brain barrier, ultimately increasing SNS activation via dysregulation of the central autonomic network comprising the insular cortex, anterior/mid-cingulate cortices, amygdala, hypothalamus, periaqueductal gray matter, parabrachial complex, nucleus of the tractus solitarius, and rostral ventrolateral medulla.4, 14, 15 Increased activation of the resting and reactive SNS could have detrimental effects on several physiological systems, including alterations in cardiac contraction,16 impairments in vascular function,17 and reductions in exercising blood flow capacity.18 The increased SNS discharge is well known to be associated with hypoxic condition that increases peripheral chemosensitivity.19 Chronic obstructive pulmonary disease has been shown to increase SNS activation mainly through chronic hypoxia, which acts by increasing the peripheral chemosensory response.20 In a sub-study of the Japan Morning Surge-Home Blood Pressure Study, decreased respiratory function assessed by percent vital capacity was associated with exaggerated ambulatory BP variability in hypertensives.21 In the CARDIA study, the lower peak forced vital capacity in young adulthood was an independent risk factor for higher visit-to-visit BP variability during middle adulthood.22 The carotid bodies, the principal peripheral chemoreceptors, are suggested to be a site of SARS-CoV-2 invasion because they are the site of the local expression of the receptor of angiotensin-converting enzyme (ACE) 2.23 Increased peripheral arterial chemosensitivity and reflex SNS overactivation might have been associated with the increased day-to-day BP variability in the critically ill COVID-19 patients reported by Li and coworkers.1 Although it is not completely clear whether increased BP variability is a cause or simply an index of decreased arterial compliance,24 one major determinant of BP variability depends on the sensitivity of baroreceptor function. Namely, vascular structural changes may reduce baroreceptor sensitivity (BRS) in hypertension.25 Decreased large arterial compliance, which contributes to the depressed BRS in young hypertensives,25 might enhance the BP fluctuations associated with minor changes in the cardiac stroke volume due to ANS instability. In the data from the United Kingdom Biobank, the patients who died due to COVID-19 had significantly higher arterial stiffness as well as significantly lower left ventricular stroke volume compared with those who survived.26 SNS overactivity, dysregulation of the renin-angiotensin system, and altered ACE-expression are suggested to lead to the adverse structural and functional remodeling of the arteries, that is, linked to the increased large arterial stiffness in patients with COVID-19.27 Moreover, higher SNS activity is associated with vasoconstriction of the coronary microvasculature, and with change in the oxygen demand of cardiomyocytes.28 Thus, in the critically ill COVID-19 patients, increased large arterial stiffness, depressed BRS, and impaired cardiac function are suggested to be pivotal determinants for the exaggerated day-to-day BP variability (Figure 1). Until now, there have been few reports assessing the relationship between day-to-day BP variability and unfavorable outcome in COVID-19. In addition to strict BP control,29, 30 it might be important to minimize day-to-day BP variability in order to prevent the deterioration of COVID-19 patients into critical illness. The data presented in the study by Li and coworkers,1 thus, make an important contribution, provided that they are considered within the context of the precise pathophysiology underlying the relationship between COVID-19 infection and day-to-day BP variability. K. Kario reports research funding from Omron Healthcare Co., Fukuda Denshi, and A&D Co. The other authors have none declared. The authors declare no conflict of interest." @default.
• W3184871422 created "2021-08-02" @default.
• W3184871422 creator A5017863780 @default.
• W3184871422 creator A5019646611 @default.
• W3184871422 creator A5024441715 @default.
• W3184871422 date "2021-07-30" @default.
• W3184871422 modified "2023-10-18" @default.
• W3184871422 title "Day‐to‐day blood pressure variability and severity of COVID‐19: Is sympathetic overdrive a potential link?" @default.
• W3184871422 cites W157299407 @default.
• W3184871422 cites W1912097681 @default.
• W3184871422 cites W2024998621 @default.
• W3184871422 cites W2105859544 @default.
• W3184871422 cites W2109145323 @default.
• W3184871422 cites W2112650958 @default.
• W3184871422 cites W2125062701 @default.
• W3184871422 cites W2125945433 @default.
• W3184871422 cites W2128414222 @default.
• W3184871422 cites W2164990391 @default.
• W3184871422 cites W2415202320 @default.
• W3184871422 cites W2595935737 @default.
• W3184871422 cites W2610356532 @default.
• W3184871422 cites W2768026175 @default.
• W3184871422 cites W2777104266 @default.
• W3184871422 cites W2808400157 @default.
• W3184871422 cites W2922383807 @default.
• W3184871422 cites W2931263538 @default.
• W3184871422 cites W3031365196 @default.
• W3184871422 cites W3040823335 @default.
• W3184871422 cites W3045454392 @default.
• W3184871422 cites W3046880631 @default.
• W3184871422 cites W3047170011 @default.
• W3184871422 cites W3081081984 @default.
• W3184871422 cites W3106634842 @default.
• W3184871422 cites W3107700148 @default.
• W3184871422 cites W3118391217 @default.
• W3184871422 cites W3122226502 @default.
• W3184871422 cites W3134849057 @default.
• W3184871422 cites W3158869393 @default.
• W3184871422 cites W3184871422 @default.
• W3184871422 cites W3188896989 @default.
• W3184871422 doi "https://doi.org/10.1111/jch.14337" @default.
• W3184871422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8420418" @default.
• W3184871422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34330153" @default.
• W3184871422 hasPublicationYear "2021" @default.
• W3184871422 type Work @default.
• W3184871422 sameAs 3184871422 @default.
• W3184871422 citedByCount "5" @default.
• W3184871422 countsByYear W31848714222021 @default.
• W3184871422 countsByYear W31848714222022 @default.
• W3184871422 countsByYear W31848714222023 @default.
• W3184871422 crossrefType "journal-article" @default.
• W3184871422 hasAuthorship W3184871422A5017863780 @default.
• W3184871422 hasAuthorship W3184871422A5019646611 @default.
• W3184871422 hasAuthorship W3184871422A5024441715 @default.
• W3184871422 hasBestOaLocation W31848714221 @default.
• W3184871422 hasConcept C10162356 @default.
• W3184871422 hasConcept C126322002 @default.
• W3184871422 hasConcept C164705383 @default.
• W3184871422 hasConcept C203014093 @default.
• W3184871422 hasConcept C2776252253 @default.
• W3184871422 hasConcept C2776533406 @default.
• W3184871422 hasConcept C2776914184 @default.
• W3184871422 hasConcept C2777372248 @default.
• W3184871422 hasConcept C2777628954 @default.
• W3184871422 hasConcept C2777953023 @default.
• W3184871422 hasConcept C2778690821 @default.
• W3184871422 hasConcept C2779134260 @default.
• W3184871422 hasConcept C2779559532 @default.
• W3184871422 hasConcept C3008058167 @default.
• W3184871422 hasConcept C524204448 @default.
• W3184871422 hasConcept C63645605 @default.
• W3184871422 hasConcept C71924100 @default.
• W3184871422 hasConcept C84393581 @default.
• W3184871422 hasConcept C8891405 @default.
• W3184871422 hasConceptScore W3184871422C10162356 @default.
• W3184871422 hasConceptScore W3184871422C126322002 @default.
• W3184871422 hasConceptScore W3184871422C164705383 @default.
• W3184871422 hasConceptScore W3184871422C203014093 @default.
• W3184871422 hasConceptScore W3184871422C2776252253 @default.
• W3184871422 hasConceptScore W3184871422C2776533406 @default.
• W3184871422 hasConceptScore W3184871422C2776914184 @default.
• W3184871422 hasConceptScore W3184871422C2777372248 @default.
• W3184871422 hasConceptScore W3184871422C2777628954 @default.
• W3184871422 hasConceptScore W3184871422C2777953023 @default.
• W3184871422 hasConceptScore W3184871422C2778690821 @default.
• W3184871422 hasConceptScore W3184871422C2779134260 @default.
• W3184871422 hasConceptScore W3184871422C2779559532 @default.
• W3184871422 hasConceptScore W3184871422C3008058167 @default.
• W3184871422 hasConceptScore W3184871422C524204448 @default.
• W3184871422 hasConceptScore W3184871422C63645605 @default.
• W3184871422 hasConceptScore W3184871422C71924100 @default.
• W3184871422 hasConceptScore W3184871422C84393581 @default.
• W3184871422 hasConceptScore W3184871422C8891405 @default.
• W3184871422 hasIssue "9" @default.
• W3184871422 hasLocation W31848714221 @default.
• W3184871422 hasLocation W31848714222 @default.
• W3184871422 hasLocation W31848714223 @default.
• W3184871422 hasOpenAccess W3184871422 @default.

• next